Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference163 articles.
1. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity: the evidence report (US Government Press, Washington DC, 1998).
2. Campfield, L. A., Smith, F. J. & Burn, P. Strategies and potential molecular targets for obesity treatment. Science 280, 1383–1387 (1998). This review outlines different strategies for obesity drug development by targeting both central and peripheral mechanisms.
3. Hill, J. O., Melanson, E. L. & Wyatt, H. T. Dietary fat intake and regulation of energy balance: implications for obesity. J. Nutr. 130, 284S–288S (2000).
4. Carriere, F. et al. Gastric and pancreatic lipase levels during a test meal in dogs. Scand. J. Gastroenterol. 28, 443–454 (1993).
5. Nordskog, B. K., Phan, C. T., Nutting, D. F. & Tso, P. An examination of the factors affecting intestinal lymphatic transport of dietary lipids. Adv. Drug Deliv. Rev. 50, 21–44 (2001).